Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in UROGEN PHARMA LTD
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 47,419 shares of URGN (UROGEN PHARMA LTD), worth $852,594 as of 2026-Q1. The position was increased (+117x shares). URGN represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$852,594
Current Shares
47,419
Total Value Change
-$21.3M
Total Shares Change
-1.3M
Other major holders of URGN: MENORA MIVTACHIM HOLDINGS LTD., BNP PARIBAS FINANCIAL MARKETS, RTW INVESTMENTS, LP
Increased |
| 47,419 |
+117x |
| $852,594 |
| 0.0% |
| $18.82 |
40 |
| 2025-Q4 | New | 403 | - | $9,438 | 0.0% | $23.17 | 26 |
| 2025-Q2 | Exited | 0 | -100.0% | $0 | 0.0% | $13.49 | 0 |
| 2025-Q1 | Increased | 4.4M | +216.6% | $48.2M | 0.0% | $11.20 | 47 |
| 2024-Q4 | Increased | 1.4M | +2.7% | $14.7M | 0.0% | $10.52 | 29 |
| 2024-Q3 | Increased | 1.3M | +1.6% | $17M | 0.0% | $12.90 | 29 |
| 2024-Q2 | New | 1.3M | - | $22.1M | 0.0% | $16.78 | 39 |